Sionna Therapeutics Inc (SION)

Jun 15, 2026

SION Q1 2026 Earnings: Wider Loss Surprises as Clinical Progress ContinuesFinal Results - newsline.com

Jun 15, 2026

Jun 13, 2026

Sionna Therapeutics - The Business Journals

Jun 13, 2026

Jun 11, 2026

Assessing Sionna Therapeutics (SION) Valuation After A Mixed Period For Recent Share Price Returns - Yahoo Finance

Jun 11, 2026

Jun 10, 2026

Transcript : Sionna Therapeutics, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-10-2026 10 - marketscreener.com

Jun 10, 2026

Jun 10, 2026

Sionna Therapeutics (SION) Gains 1.81% as Biotech Sentiment ImprovesAdaptive Moving Average - newsline.com

Jun 10, 2026

Jun 07, 2026

SION Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Faces Investor SkepticismGrowth Acceleration Report - newsline.com

Jun 07, 2026

Jun 03, 2026

Biotech Sionna Therapeutics at Jefferies and Goldman Sachs in June - Stock Titan

Jun 03, 2026

May 30, 2026

Sionna Therapeutics director Peter Thompson sells $4,493 of shares - Investing.com India

May 30, 2026

May 29, 2026

Sionna Therapeutics director Peter Thompson sells $4,493 of shares By Investing.com - Investing.com South Africa

May 29, 2026

May 29, 2026

OrbiMed Advisors, director, sells $4,493 in Sionna Therapeutics stock - Investing.com

May 29, 2026

May 29, 2026

OrbiMed Advisors, director, sells $4,493 in Sionna Therapeutics stock By Investing.com - Investing.com UK

May 29, 2026

May 29, 2026

Form 144 | Sionna Therapeutics(SION.US) Insider Proposes to Sell 46.33 Million in Common Stocks - Moomoo

May 29, 2026

May 28, 2026

Sionna Therapeutics (SION) Sees Slight Decline Amidst Key Support TestPre-Earnings Momentum - The Legal Advocate

May 28, 2026

May 28, 2026

SIONSionna Therapeutics Inc. stock news, filings & ratings - Quantisnow

May 28, 2026

May 27, 2026

Sionna Therapeutics (SION) Edges Higher as Biotech Sentiment Improves — Testing Key ResistanceAdvance Decline Volume - thelegaladvocate.com

May 27, 2026

May 27, 2026

Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences - markets.businessinsider.com

May 27, 2026

May 26, 2026

SION Reiterates by Citizens -- Price Target Maintained at $63 - GuruFocus

May 26, 2026

May 26, 2026

Stifel Nicolaus Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION) - The Globe and Mail

May 26, 2026

May 26, 2026

Stifel reiterates Buy on Sionna Therapeutics stock ahead of data - Investing.com

May 26, 2026

May 26, 2026

Stifel reiterates Buy on Sionna Therapeutics stock ahead of data By Investing.com - Investing.com Canada

May 26, 2026

May 26, 2026

Citizens reiterates Sionna Therapeutics stock rating on CF treatment potential By Investing.com - Investing.com Canada

May 26, 2026

May 25, 2026

SION Q1 2026 Earnings: Clinical-Stage Biotech Misses Estimates with Wider Net LossEarnings Growth Forecast - newsline.com

May 25, 2026

May 24, 2026

Number of shareholders of Sionna Therapeutics, Inc. – NASDAQ:SION - TradingView

May 24, 2026

May 24, 2026

A Quick Look at Today's Ratings for Sionna Therapeutics(SION.US), With a Forecast Between $50 to $63 - Moomoo

May 24, 2026

May 21, 2026

Freedom Broker downgrades Sionna Therapeutics (SION) - MSN

May 21, 2026

May 21, 2026

Sionna Therapeutics Cut to Hold From Buy by Freedom Broker - Moomoo

May 21, 2026

May 20, 2026

SION: Phase II data for two NBD1 stabilizers in CF expected this summer, aiming for superior efficacy - TradingView

May 20, 2026

May 20, 2026

Sionna Therapeutics Price Target Maintained With a $38.00/Share by Freedom Broker - Moomoo

May 20, 2026

May 20, 2026

Sionna Therapeutics stock rating cut to Hold at Freedom Broker By Investing.com - Investing.com Canada

May 20, 2026

May 19, 2026

SION Maintained by Stifel -- Price Target Raised to $55 - GuruFocus

May 19, 2026

May 18, 2026

Sionna Therapeutics Price Target Raised to $55.00/Share From $44.00 by Stifel - Moomoo

May 18, 2026

May 18, 2026

Wedbush Maintains Sionna Therapeutics(SION.US) With Buy Rating, Maintains Target Price $53 - Moomoo

May 18, 2026

May 18, 2026

Stifel raises Sionna Therapeutics price target on NBD1 data confidence By Investing.com - Investing.com Canada

May 18, 2026

May 18, 2026

Sionna Therapeutics (SION) Stock: Slides -0.80%, Support at $37.90 2026-05-18Strangle Setup - newsline.com

May 18, 2026

May 17, 2026

User - FinancialContent

May 17, 2026

May 16, 2026

Wedbush initiates coverage of Sionna Therapeutics (SION) with outperform recommendation - MSN

May 16, 2026

May 16, 2026

Sionna Therapeutics, Inc. $SION Shares Purchased by Vanguard Group Inc. - MarketBeat

May 16, 2026

May 15, 2026

Sionna Therapeutics Develops Next-Generation Cystic Fibrosis Modulators - HarianBasis.co

May 15, 2026

May 14, 2026

RBC Capital Sticks to Its Sell Rating for Sionna Therapeutics, Inc. (SION) - The Globe and Mail

May 14, 2026

May 14, 2026

Wedbush Initiates Coverage of Sionna Therapeutics (SION) - Insider Monkey

May 14, 2026

May 13, 2026

Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference - The Manila Times

May 13, 2026

May 13, 2026

Yazdi Reiterates Buy on Sionna, Keeps $58 Price Target Ahead of High-Impact 2026 SION-719 Readout - TipRanks

May 13, 2026

May 13, 2026

LifeSci Capital Maintains Sionna Therapeutics(SION.US) With Buy Rating, Maintains Target Price $60 - Moomoo

May 13, 2026

May 12, 2026

Sionna Therapeutics Q1 Net Loss Narrows - Moomoo

May 12, 2026

May 12, 2026

Sionna Therapeutics (NASDAQ:SION) Stock Price Down 10.4% on Disappointing Earnings - MarketBeat

May 12, 2026

May 12, 2026

Guggenheim reiterates Sionna Therapeutics stock rating at Buy By Investing.com - Investing.com Canada

May 12, 2026

May 12, 2026

Raymond James reiterates Strong Buy on Sionna stock ahead of summer data - Investing.com

May 12, 2026